“Depression Screening Market” 2018 Scope | 6.20% CAGR to Be Observed in the Depression Screening Market by the End of the Year | MRFR Unleashes Industry Insights Up To 2023

Market Research Future (MRFR)
This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Depression Screening Market over the forecast period. The global depression screening market is expected to grow at a CAGR of 6.20% during the forecast period 2017-2023.

MarketResearchFuture.com adds “Depression Screening Market – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2023” reports to its database.

Market Highlights:

Depression is a kind of mental condition that causes individuals to experience depressed mood, loss of interest, feelings of low self-worth, disturbed sleep or appetite, low energy, and poor concentration. An individual who is suffering from depression experiences intense emotions of anxiety, hopelessness, negativity and helplessness. The global depression screening/mental health market has been evaluated as a moderately growing market and it is expected to continue growing in the near future. Increasing cases of patients with various mental disorders, changing and stressful lifestyle are driving the growth for the market. Moreover, rising funding for R&D and clinical trials are also driving the growth for the market. Major players of this industry are funding R&D to derive effective solutions for mental health. Major players of this market are holding majority of market share while due to high investment cost, medium and small companies mainly focusing only on manufacturing of drugs rather than R&D. For instance, companies like Eli Lilly and Company, Pfizer Inc., Allergan and some other are spending a rather large amount on R&D for market growth.

Taste the market data and market information presented through more than 113 market data tables and 16 figures spread over 101 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Depression Screening Market Research Report–Global forecast till 2023.”

Major Players in the Depression Screening Market:

Some of the key players in the global market are Alkermes (Republic of Ireland), ALLERGAN (Republic of Ireland), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Novartis AG (Switzerland), Otsuka Holdings Co.,Ltd. (Japan),  Pfizer Inc. (US), and others.

Research Methodology:

You can get easy access to sample report here, please click: https://www.marketresearchfuture.com/sample_request/3806 .

Key Findings:

On the basis of disease type, anxiety is the largest segment and continue to grow with the rate of 5.14% during the forecast period. While depression is the fastest growing segment and is projected to grow at a CAGR of 6.63% from 2016-2023.

On the basis of diagnosis, psychological test is the most widely used diagnostic test in depression screening protocol and is expected to reach USD 1,647.6 million in the year 2023 from USD 1,059.6 million in 2016

On the basis of treatment, medications is the fastest growing market, which is expected to reach USD 1,949.2 million by 2023.


The global depression screening market is segmented on the basis of disease type, diagnosis, treatment, and end user.

On the basis of the disease type, it is further segmented into anxiety, mood disorders, depression, bipolar disorders, psychotic disorders, eating disorders and other mental and behavioral & disorders.

On the basis of the diagnosis, the market is segmented into psychological test, Lab tests, depression screening tests and others.

On the basis of the treatment, the market is segmented into medication (anti-anxiety medications, antidepressants, antipsychotic medications, stimulants, anti-seizures medications and others), brain-stimulation treatments (Vagus Nerve Stimulation (VNS), repetitive Transcranial Magnetic Stimulation (rTMS), Magnetic Seizure Therapy (MST), and Deep Brain Stimulation (DBS)), substance abuse treatment and others.

On the basis of the end user, the market is segmented into hospitals and clinics, medical research centers, academic institutes, and others.

Figure: Global Depression screening Market, by Disease Type, 2016 (%)

Any query or specific requirement? Ask to our industry expert, please click: https://www.marketresearchfuture.com/enquiry/3806 .

Regional Analysis:

The global depression screening market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

Americas is known to be the largest market. Many top global pharmaceutical companies have their base in this region leading the innovation and new solution development. These companies like Eli Lilly and Company, Pfizer Inc. and some other are spending a rather large amount on R&D for market growth.  According to Canadian Mental Health Association, 1% Canadian population is suffering from Schizophrenia while 5% of Canadian household population is suffering from anxiety disorders.

The cases of mental disorder and illness is rapidly rising in Europe. Some major factors are leading the growth of European depression screening/mental health market such as changing lifestyle is leading to stress, increasing prevalence of depression, rapid adoption of new drugs and techniques etc. According to World Health Organization (WHO), about 27% adult population of European Union (EU) countries suffers fro vm at least one series of mental disorder and 3 out of 4 people are suffering from major depression.

Prevalence of various mental disorders are rapidly rising in middle-low income countries. According data published in International Journal of Behavioral Science, anxiety, depression, Post-Traumatic Stress Disorder (PTSD), substance abuse disorder, and suicidal behavior are the top five mental problem in Asia Pacific region. Increasing awareness of mental disorders and treatments are driving the growth for the market.

Middle Eastern countries are dominating in Middle East and Africa market it is mostly due to developed healthcare infrastructure, government support, increasing awareness and rising middle class population. However some factor are prohibiting the market growth such as low awareness of the disorders, reluctance to adopt new therapies, and limited availability of healthcare facilities and products etc.

What makes our report unique?

1) An extensive research study on the Global Depression Screening market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Depression Screening market.

2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.

3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.


Feel free to get in touch for discounts and customized details, please click: https://www.marketresearchfuture.com/check-discount/3806 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/depression-screening-mental-health-market-3806